| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | E.coli-derived human INAVA recombinant protein (Position: Q236-V663) was used as the immunogen for the INAVA antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
INAVA Antibody / Innate immunity activator is an antibody targeting INAVA. Host: Rabbit. Polyclonal. Format: Lyophilized. Applications: WB, ELISA.
Key elements and design rationale
- Target: INAVA.
- Immunogen: E.coli-derived human INAVA recombinant protein (Position: Q236-V663) was used as the immunogen for the INAVA antibody..
- Species reactivity: Human.
- Conjugate: Unconjugated (no label listed).
Biological background (from provided description)
INAVA antibody detects Innate immunity activator, encoded by the INAVA gene on chromosome 1q32.1. INAVA antibody is commonly used to investigate the immune-regulatory roles of this adaptor protein, which contributes to barrier defense and epithelial homeostasis.
Common research applications
- WB: relative abundance and band pattern assessment using appropriate controls.
Notes for experimental interpretation
- Account for isoforms, paralogs, and post-translational modifications when interpreting signal.
- Support specificity with biological controls (e.g., KO/KD where available) and technical controls (e.g., secondary-only/isotype).
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
